Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Oncimmune Set For Bigger US Push Of Early-Stage Lung Cancer Test

This article was originally published in Clinica

Executive Summary

Oncimmune Ltd is seeking new distribution partners in the US as it expands the commercialization of its blood-based immunoassay for early-stage lung cancer, the only one of its kind in the market.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register